U.S. Markets closed

Pfenex Inc. (PFNX)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
12.75+0.06 (+0.47%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close12.76
Open12.68
Bid0.00 x 900
Ask0.00 x 900
Day's Range12.76 - 12.93
52 Week Range5.26 - 14.00
Volume1,625,351
Avg. Volume921,615
Market Cap437.282M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateNov 04, 2020 - Nov 09, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est13.00
  • Ligand Announces Expiration of Tender Offer for Shares of Pfenex Inc.
    Business Wire

    Ligand Announces Expiration of Tender Offer for Shares of Pfenex Inc.

    Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that its tender offer to purchase any and all issued and outstanding shares of common stock of Pfenex Inc. (NYSE American: PFNX) at an offer price of $12.00 per share in cash, plus one non-transferable contractual contingent value right per share representing the right to receive a contingent payment of $2.00 in cash, if a certain specified milestone is achieved, expired at midnight (New York City time), at the end of the day on Tuesday, September 29, 2020.

  • Monteverde & Associates Reminds Shareholders of its Ongoing Investigation Regarding the Merger
    ACCESSWIRE

    Monteverde & Associates Reminds Shareholders of its Ongoing Investigation Regarding the Merger

    NEW YORK, NY / ACCESSWIRE / September 25, 2020 / Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City, is investigating: * Pfenex Inc.

  • GlobeNewswire

    Lifshitz Law Firm, P.C. Announces Investigation of Pfenex Inc. (NYSE: PFNX), Proteostasis Therapeutics, Inc. (NASDAQ: PTI), Rosetta Stone Inc. (NYSE:RST) and Yintech Investment Holdings Limited (NASDAQ: YIN)

    NEW YORK, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Pfenex Inc. (NYSE: PFNX)Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of PFNX to Ligand Pharmaceuticals Incorporated.If you are a PFNX investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.Proteostasis Therapeutics, Inc. (NASDAQ: PTI)Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the merger of PTI with Yumanity Therapeutics.If you are a PTI investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.Rosetta Stone Inc. (NYSE: RST)Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of RST to Cambium Learning Group for $30 per share.If you are a RST investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.Yintech Investment Holdings Limited (NASDAQ: YIN)Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of YIN to members of YIN management.If you are a YIN investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua Lifshitz, Esq. by telephone at (516)493-9780 or e-mail at info@jlclasslaw.com.ATTORNEY ADVERTISING.© 2020 Lifshitz Law Firm, P.C.  The law firm responsible for this advertisement is Lifshitz Law Firm, P.C., 821 Franklin Avenue, Suite 209, Garden City, New York 11530, Tel: (516)493-9780.  Prior results do not guarantee or predict a similar outcome with respect to any future matter.Contact:Joshua M. Lifshitz, Esq. Lifshitz Law Firm, P.C. Phone:  516-493-9780 Facsimile: 516-280-7376 Email: info@jlclasslaw.com